WebbFör 1 dag sedan · The phase 3 KEYNOTE-522 trial (NCT03036488) was the first prospective study to show improved event-free survival (EFS) with pembrolizumab (Keytruda) plus neoadjuvant chemotherapy in high-risk ... Webb14 dec. 2024 · Rare Diseases Report 2024 . Rare GU cancers: Overcoming obstacles through collaboration, novel trial design. Publish date: December 14, 2024
Oncology – Landmark Trials
Webb23 dec. 2024 · Nature Medicine asks leading researchers to name their top clinical trial for 2024, from cervical and prostate cancer screening to new drugs for Parkinson’s disease … Webbför 23 timmar sedan · SAN FRANCISCO, April 13, 2024 (GLOBE NEWSWIRE) -- Olema Pharmaceuticals, Inc. (“Olema”, “Olema Oncology”, Nasdaq: OLMA), a clinical-stage biopharmaceutical company focused on the discovery ... flaster law group
WikiJournalClub:List of landmark papers/Oncology
http://mdedge.ma1.medscape.com/hematology-oncology/article/176346/lung-cancer/impower132-trial-atezolizumab-improves-pfs-advanced Webb15 aug. 2024 · This book describes the evolution of treatment in oncology through the lens of approximately 250 landmark clinical trials. The well … Webb18 mars 2024 · PHILADELPHIA, March 18, 2024 /PRNewswire/ -- CARISMA Therapeutics Inc., a clinical stage biopharmaceutical company spun out of the University of P... fla st bowl game